Intellectual Property Concerns in Biotech & Pharma MasterClass - US edition

This MasterClass will provide you with the basic tools and understanding needed to engage with colleagues in meaningful discussions about different types of IP, the value of IP, how IP is used on a daily basis in the marketplace, and how IP is acquired and maintained.

25-26 March, 2024, Virtual

Time Zone: Eastern Standard Time (EST) / UTC−05:00

Overview

This MasterClass will provide you with the basic tools and understanding needed to engage with colleagues in meaningful discussions about different types of IP, the value of IP, how IP is used on a daily basis in the marketplace, and how IP is acquired and maintained. Additionally, business leaders in the biotech and pharmaceutical sciences without prior formal training in IP will learn how to spot potential IP issues and to evaluate IP in a merger, acquisition, licensing deal, or other IP-relevant transaction. This course is not geared towards current IP professionals such as attorneys or licensing professionals who already possess a functional understanding of IP. Rather, this course is geared towards C-level executives, project or program managers, general counsel, paralegals, and others in the biotech and pharmaceutical fields who may feel somewhat intimidated by the topic, wish to contribute to the IP discussions when they arise, and need to be able to spot IP issues on a daily basis in their role within their company or industry.

#masterclass     #glceurope      #pharmaonlinetraining      #globalleadingconferences       #intellectualproperty       #biotech

RECOMMENDATION

Who should attend?

• C-level executive
• CEO, CSO, CTO, CLO
• Program manager
• Project manager
• VP
• Paralegal
• Legal assistant
• General counsel
• R&D
• Grant manager